Abstract
Data from 215 pregnant women exposed to varicella and 276 with varicella observed at the Tuscany Reference Center for Infectious Diseases in Pregnancy, Florence, Italy, in the period 1997–2016 were retrospectively collected. The risk of developing varicella was lower in exposed women who received varicella zoster immunoglobulin compared with those who did not receive it [42% (21 of 50) vs 72% (13 of 18); p = 0.0263]. Typical congenital varicella syndrome was observed in 1.56% of fetuses/neonates born from pregnant women with varicella.
Similar content being viewed by others
References
Lamont RF, Sobel JD, Carrington D, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, et al. Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG. 2011;118(10):1155–62. https://doi.org/10.1111/j.1471-0528.2011.02983.x.
Harger JH, Ernest JM, Thurnau GR, Moawad A, Momirova V, Landon MB, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis. 2002;185(4):422–7. https://doi.org/10.1086/338832.
Gershon A, Marin M, Seward J. Varicella. Measles and Mups. In: Wilson C, Nized V, Maldonado Y, Remington J, Klein J, editors. Remington and Klein’s infectious diseases of the fetus and newborn infant, 8th edn. Philadelphia: Elsevier Saunders; 2016. pp 675–723.
Harris RE, Rhoades ER. Varicella pneumonia complicating pregnancy. Report of a case and review of literature. Obstet Gynecol. 1965;25:734–40.
Sterner G, Forsgren M, Enocksson E, Grandien M, Granström G. Varicella-zoster infections in late pregnancy. Scand J Infect Dis Suppl. 1990;71:30–5.
Ahn KH, Park YJ, Hong SC, Lee EH, Lee JS, Oh MJ, et al. Congenital varicella syndrome: a systematic review. J Obstet Gynaecol. 2016;36(5):563–6. https://doi.org/10.3109/01443615.2015.1127905.
Sauerbrei A, Wutzler P. The congenital varicella syndrome. J Perinatol. 2000;20(8 Pt 1):548–54.
Booy R, Burgner D, Nissen M, Buttery J, Zurynski Y, Elliott E, et al. Congenital Varicella Syndrome, study protocol. Case definition and reporting instructions: Australian Paediatric Surveillance Unit; 2006. http://www.apsu.org.au/assets/current-studies/Congenital-Varicella-2005-protocol-sheet130810.pdf. Accessed 14 May 2018.
Centers for Disease Control and Prevention (CDC). FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella. MMWR Morb Mortal Wkly Rep. 2012;61(12):212.
Centers for Disease Control and Prevention (CDC). Updated recommendations for use of VariZIG–United States. MMWR Morb Mortal Wkly Rep. 2013;62(28):574–6.
Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, et al. Impact of universal vaccination against varicella in Italy. Human Vaccin Immunother. 2015;11(1):63–71. https://doi.org/10.4161/hv.34311.
Italian Ministry of Health National Immnunization Prevention Plan 2017–2019. IPublished on the italian official gazette, February 18th 2017. http://www.gazzettaufficiale.it/eli/id/2017/02/18/17A01195/sg. Accessed 14 May 2018.
Jespersen C, Helmuth IG, Krause TG. Varicella-zoster immunoglobulin treatment in pregnant women in Denmark from 2005 to 2015: descriptive epidemiology and follow-up. Epidemiol Infect. 2016. https://doi.org/10.1017/s0950268816001485.
Bapat P, Koren G. The role of VariZIG in pregnancy. Expert Rev Vaccin. 2013;12(11):1243–8. https://doi.org/10.1586/14760584.2013.844651.
Subramaniam A, Britt WJ. Herpesviridae infection: prevention, screening, and management. Clin Obstet Gynecol. 2018;61(1):157 – 76. https://doi.org/10.1097/grf.0000000000000335.
Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994;343(8912):1548–51.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Trotta, M., Borchi, B., Niccolai, A. et al. Epidemiology, management and outcome of varicella in pregnancy: a 20-year experience at the Tuscany Reference Centre for Infectious Diseases in Pregnancy. Infection 46, 693–699 (2018). https://doi.org/10.1007/s15010-018-1150-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-018-1150-4